DK3546569T3 - Terapeutiske midler med anvendelse af fedtceller og cellesekreter - Google Patents

Terapeutiske midler med anvendelse af fedtceller og cellesekreter Download PDF

Info

Publication number
DK3546569T3
DK3546569T3 DK19153401.5T DK19153401T DK3546569T3 DK 3546569 T3 DK3546569 T3 DK 3546569T3 DK 19153401 T DK19153401 T DK 19153401T DK 3546569 T3 DK3546569 T3 DK 3546569T3
Authority
DK
Denmark
Prior art keywords
therapeutic methods
fat cells
cell secrets
secrets
cell
Prior art date
Application number
DK19153401.5T
Other languages
English (en)
Inventor
Graham Vesey
Rebecca Anne Webster
Richard Lilischkis
Original Assignee
Cell Ideas Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011903938A external-priority patent/AU2011903938A0/en
Application filed by Cell Ideas Pty Ltd filed Critical Cell Ideas Pty Ltd
Application granted granted Critical
Publication of DK3546569T3 publication Critical patent/DK3546569T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0667—Adipose-derived stem cells [ADSC]; Adipose stromal stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
DK19153401.5T 2011-09-23 2012-09-21 Terapeutiske midler med anvendelse af fedtceller og cellesekreter DK3546569T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2011903938A AU2011903938A0 (en) 2011-09-23 Therapeutic methods and compositions
AU2012901350A AU2012901350A0 (en) 2012-04-04 Therapeutic methods and compositions
AU2012903646A AU2012903646A0 (en) 2012-08-23 Therapeutic methods and compositions
EP12833860.5A EP2744892B1 (en) 2011-09-23 2012-09-21 Therapeutics using adipose cells and cell secretions

Publications (1)

Publication Number Publication Date
DK3546569T3 true DK3546569T3 (da) 2021-07-12

Family

ID=47913679

Family Applications (2)

Application Number Title Priority Date Filing Date
DK19153401.5T DK3546569T3 (da) 2011-09-23 2012-09-21 Terapeutiske midler med anvendelse af fedtceller og cellesekreter
DK12833860.5T DK2744892T3 (da) 2011-09-23 2012-09-21 Terapeutik, der anvender fedtceller og cellesekretioner

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK12833860.5T DK2744892T3 (da) 2011-09-23 2012-09-21 Terapeutik, der anvender fedtceller og cellesekretioner

Country Status (9)

Country Link
US (3) US10111909B2 (da)
EP (3) EP2744892B1 (da)
JP (5) JP6162123B2 (da)
AU (1) AU2012313352B2 (da)
CA (1) CA2885487C (da)
DK (2) DK3546569T3 (da)
ES (2) ES2880084T3 (da)
SG (2) SG10201606745XA (da)
WO (1) WO2013040649A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9192695B2 (en) 2008-11-20 2015-11-24 Allosource Allografts combined with tissue derived stem cells for bone healing
JP2023002772A (ja) * 2011-09-23 2023-01-10 レジニアス リミテッド 脂肪細胞および細胞分泌物を使用する治療
EP2744892B1 (en) * 2011-09-23 2019-03-20 Cell Ideas Pty Ltd. Therapeutics using adipose cells and cell secretions
AU2013204930C1 (en) * 2012-09-26 2015-01-22 Cell Ideas Pty Ltd Therapeutics using multiple injections of cells
EP2919794B1 (en) 2012-11-15 2021-01-20 AlloSource Minced cartilage systems and methods
CA2934958A1 (en) 2012-12-24 2014-07-03 Cell Ideas Pty Ltd Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
WO2014130883A2 (en) 2013-02-22 2014-08-28 Allosource Cartilage mosaic compositions and methods
WO2014151939A1 (en) 2013-03-15 2014-09-25 Allosource Perforated osteochondral allograft compositions
KR102312720B1 (ko) 2013-03-15 2021-10-13 알로소스 연조직 회복 및 재생을 위한 세포 재배치된 콜라겐 매트릭스
JP2016523083A (ja) * 2013-06-19 2016-08-08 スパイナルサイト， エルエルシー 軟骨細胞適用のための脂肪細胞
EP3052943B1 (en) * 2013-10-04 2019-11-20 Cell Ideas Pty Ltd. Biomarkers for cell therapy
JP2018501241A (ja) 2014-12-19 2018-01-18 セル・アイディアズ・ピーティーワイ・リミテッド 改良された細胞療法
WO2017041133A1 (en) 2015-09-08 2017-03-16 Cell Ideas Pty Ltd Cell expansion methods and therapeutic compositions
CN108289915A (zh) * 2015-11-24 2018-07-17 日本乐敦制药株式会社 包含脂肪组织来源基质细胞的肝病治疗剂及其制造方法
EP3624816A4 (en) 2017-05-15 2021-02-24 Stem Cell Medicine Ltd. TREATMENT OF MULTIPLE SCLEROSIS WITH ADAPTIVE STEM CELLS
CA3062964A1 (en) 2017-05-15 2018-11-22 Stem Cell Medicine Ltd. Treatment of multiple sclerosis with long acting glatiramer and adipose-derived stem cells
MX2019014426A (es) * 2017-10-02 2020-02-05 Fukuoka Hirotaro Composicion farmaceutica para usarse en la mejora de la calidad del cuero cabelludo y la piel, de la cicatrizacion de heridas o mejora de la calidad del cabello.
KR20210021358A (ko) * 2018-06-15 2021-02-25 파르도 루이스 마리나스 약제학적 피부과 조성물 및 그 용도
JP7429032B2 (ja) * 2019-12-24 2024-02-07 学校法人順天堂 間質性肺炎モデル非ヒト動物の作製方法
JP6826744B1 (ja) * 2020-07-17 2021-02-10 医療法人Ｙａｎａｇａ ＣＬｉｎｉｃ 成熟脂肪細胞含有組成物の製造方法
CN114452303A (zh) * 2020-11-10 2022-05-10 上海萨美细胞技术有限公司 无细胞脂肪提取液对关节炎的治疗用途
IT202100003062A1 (it) * 2021-02-11 2022-08-11 Gaia Margiotta "processo di crioconservazione di tessuto adiposo"
CN115521908A (zh) * 2022-10-24 2022-12-27 潍坊天创生物科技有限公司 一种脂肪间充质干细胞的体外培养及外泌体的分离纯化方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037175A (en) 1996-03-12 2000-03-14 The University Of South Florida Method and media for enhancing cryopreservation of cells
US7078232B2 (en) * 1999-08-19 2006-07-18 Artecel, Inc. Adipose tissue-derived adult stem or stromal cells for the repair of articular cartilage fractures and uses thereof
US20030054331A1 (en) 2001-09-14 2003-03-20 Stemsource, Inc. Preservation of non embryonic cells from non hematopoietic tissues
WO2003040346A2 (en) * 2001-11-09 2003-05-15 Artecel Sciences, Inc. Methods and compositions for the use of stromal cells to support embryonic and adult stem cells
EP1572071B1 (en) * 2001-12-07 2018-10-03 Cytori Therapeutics, Inc. Methods for preparing fresh adipose tissue-derived cells and uses in treating patients
JP2007508018A (ja) * 2003-10-08 2007-04-05 べト−ステム インコーポレイテッド 新規の幹細胞組成物の調製法および使用法、ならびにこの組成物を含有するキット
US8715733B2 (en) * 2004-07-23 2014-05-06 DePuy Synthes Products, LLC Enhanced adipose tissue
US20100092432A1 (en) * 2006-08-08 2010-04-15 Takenori Ozaki Cell preparation containing multipotential stem cells originating in fat tissue
AU2007320031B2 (en) 2006-10-06 2013-05-02 University Of Virginia Patent Foundation Methods and compositions useful for diabetic wound healing
AU2009227022B2 (en) 2008-03-19 2014-07-03 Cryo-Save Ag Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
WO2009152084A2 (en) 2008-06-11 2009-12-17 Cell4Vet Llc Adipose tissue-derived stem cells for veterinary use
AU2009201915C1 (en) 2008-08-22 2015-02-26 Regeneus Ltd Therapeutic methods
JP5647230B2 (ja) * 2009-04-28 2014-12-24 アントロジェン カンパニー リミテッドＡｎｔｅｒｏｇｅｎ Ｃｏ．， Ｌｔｄ． 瘻孔治療のための自家及び同種異系の脂肪由来間質幹細胞組成物
US20120201791A1 (en) 2009-10-15 2012-08-09 Tai June Yoo Methods of treating diseases or conditions using mesenchymal stem cells
JP6038821B2 (ja) * 2011-03-15 2016-12-07 セル・アイディアズ・ピーティーワイ・リミテッド 医薬組成物およびその局所使用
EP2744892B1 (en) 2011-09-23 2019-03-20 Cell Ideas Pty Ltd. Therapeutics using adipose cells and cell secretions

Also Published As

Publication number Publication date
SG2014013676A (en) 2014-05-29
JP2017193566A (ja) 2017-10-26
EP3546569B1 (en) 2021-06-16
US20140234272A1 (en) 2014-08-21
JP6839038B2 (ja) 2021-03-03
EP2744892A4 (en) 2015-05-20
EP3546569A1 (en) 2019-10-02
DK2744892T3 (da) 2019-04-23
ES2721180T3 (es) 2019-07-29
JP2019142971A (ja) 2019-08-29
US10660921B2 (en) 2020-05-26
WO2013040649A1 (en) 2013-03-28
SG10201606745XA (en) 2016-10-28
AU2012313352B2 (en) 2015-07-02
JP7022863B2 (ja) 2022-02-18
JP2022033865A (ja) 2022-03-02
JP2021155461A (ja) 2021-10-07
AU2012313352A1 (en) 2013-05-02
EP3868871A1 (en) 2021-08-25
JP6912512B2 (ja) 2021-08-04
JP2014527821A (ja) 2014-10-23
EP2744892B1 (en) 2019-03-20
AU2012313352A9 (en) 2013-09-26
ES2880084T3 (es) 2021-11-23
EP2744892A1 (en) 2014-06-25
CA2885487A1 (en) 2013-03-28
CA2885487C (en) 2021-11-16
US20200261510A1 (en) 2020-08-20
US20190015455A1 (en) 2019-01-17
JP6162123B2 (ja) 2017-07-12
US10111909B2 (en) 2018-10-30

Similar Documents

Publication Publication Date Title
DK3546569T3 (da) Terapeutiske midler med anvendelse af fedtceller og cellesekreter
DK3260140T3 (da) Fremgangsmåder og produkter til transficering af celler
DK2686421T3 (da) Generering af nk-celler og nk-celleforløbere
DK3354665T3 (da) Modificerede alginater til celleindkapsling og celleterapi
DK2555807T5 (da) Skabelon-øceller og små øcelleklynger til behandling af diabetes
DK3045187T3 (da) Injektor og fremgangsmåde til samling
DK3578201T3 (da) Fremgangsmåder og sammensætninger til naturlige dræberceller
BR112012009921A2 (pt) métodos para reprogramar células e usos do mesmos
EP2811011A4 (en) CELL CULTURE KIT AND METHOD FOR USING THE CELL CULTURE KIT
DK3257943T3 (da) Fremgangsmåder og vektorer til celleimmortalisering
DK2950535T3 (da) Fremgangsmåde og indretning til at afkode intra-forudsigelsestilstand
DK2764459T3 (da) Fremgangsmåder og processer til ikke-invasiv bedømmelse af genetiske variationer
IL230237B (en) Fat Cell Compounds and Methods
DK2734128T3 (da) Kirurgisk hentningsindretning med halvstift udtrækkelig og sammenklappelig kurv
DK3622883T3 (da) Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
EP2696395A4 (en) SEPARATOR AND ELECTROCHEMICAL DEVICE THEREWITH
DK2705143T3 (da) Protein-induceret pluripotent celleteknologi og anvendelse deraf
DK2678283T3 (da) Vanadiumbaserede frittematerialer og fremgangsmåder til deres fremstilling
HK1207956A1 (en) Methods and devices for cervical cell and tissue sampling
DK2638149T3 (da) Immortalisering af epitelceller og fremgangsmåder til anvendelse
DK2923400T3 (da) Reduktion af gasning i lithiumtitanatceller
DK2817406T3 (da) Engangsseparator til tilbageholdelse og tilbageføring af celler
DK2693816T3 (da) Fremgangsmåde og enhed til brug i rammegenkendelse
ZA201407456B (en) User equipment mobility in networks including small cells
DK3067578T3 (da) Leje med tre og flere rækker af rulleelementer